Sweetening Pharmaceutical Radiochemistry by18F-Fluoroglycosylation: A Short Review
Author(s) -
Simone Maschauer,
Olaf Prante
Publication year - 2014
Publication title -
biomed research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 126
eISSN - 2314-6141
pISSN - 2314-6133
DOI - 10.1155/2014/214748
Subject(s) - glycoconjugate , chemistry , radiochemistry , sweetening , combinatorial chemistry , in vivo , nucleophilic substitution , biochemistry , organic chemistry , sweetening agents , biology , microbiology and biotechnology , food science
At the time when the highly efficient [ 18 F]FDG synthesis was discovered by the use of the effective precursor 1,3,4,6-tetra- O -acetyl-2- O -trifluoromethanesulfonyl- β -D-mannopyranose (mannose triflate) for nucleophilic 18 F-substitution, the field of PET in nuclear medicine experienced a long-term boom. Thirty years later, various strategies for chemoselective 18 F-labeling of biomolecules have been developed, trying to keep up with the emerging field of radiopharmaceutical sciences. Among the new radiochemical strategies, chemoselective 18 F-fluoroglycosylation methods aim at the sweetening of pharmaceutical radiochemistry by providing a powerful and highly valuable tool for the design of 18 F-glycoconjugates with suitable in vivo properties for PET imaging studies. This paper provides a short review (reflecting the literature not older than 8 years) on the different 18 F-fluoroglycosylation reactions that have been applied to the development of various 18 F-glycoconjugate tracers, including not only peptides, but also nonpeptidic tracers and high-molecular-weight proteins.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom